ID: MRFR/HC/7096-HCR | February 2021 | Region: Global | 125 pages
Microtome Market accounted for USD 120 Million in 2018 at a CAGR of 6.1%.
A microtome is a tool used to cut extremely thin sections of tissue samples of plants or animals. Microtomes help in extremely fine cuts that are important for preparations used in microscopy. The high preference of microtome in cancer biopsy will drive the growth positively over the forecast period due to rising cases of cancer worldwide. According to WHO, around 18.1 million new cases of cancer were diagnosed in 2018.
The increasing incidence of chronic disorders, rising geriatric population along with growing commercial availability of high-quality diagnostic technologies in developed economies, support the market growth. The ever-increasing number of clearances and product launches by key players in the market are likely to act as a promising factor for the growth of the microtome market in the near future. For instance, in May 2018, Leica Biosystems, part of Danaher introduced a new line of rotary microtomes to its full line of histology equipment and consumables. This product launch includes products such as HistoCore BIOCUT, HistoCore MULTI CUT, and HistoCoreAUTOCUT clinical microtomes.
Frequently Asked Questions (FAQ) :
Microtome market is projected grow at approximately 6.1% CAGR during the assessment period (2017-2023).
The valuation of the global Microtome market had reached 120 MN in 2018.
The instruments segment by product holds the majority shares in the global Microtome market.
North America holds the largest share in the global Microtome market, followed by Europe and the Asia Pacific, respectively.
Danaher (US), Amos Scientific Pty Ltd (Australia), Diapath S.p.A. (Italy), Jinhua YIDI Medical Appliance Co., Ltd (China), Histo-Line Laboratories (Italy), MEDITE GmbH (Germany), Sakura Finetek (Japan), Boeckeler Instruments, Inc. (US), Thermo Fisher Scientific (US), and SLEE Medical GmbH (Germany), are some of the major players operating in the global Microtome market.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.